Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx: Unveiling the Impact of Genetics on Health

PlexusDx stands out as the top personalized health report provider and strives to reveal how genetics affects our health. Our focus today is on the AHCY gene which plays an essential role in methylation and homocysteine metabolism with potential significant health implications. The fundamental biological process of methylation transfers methyl groups between compounds to function as gene expression regulators that respond to environmental signals in the epigenetic phenomenon. Methyl groups serve as vital signals for the breakdown and elimination of hormones and brain chemicals along with amino acids which help to sustain an essential equilibrium throughout the body. The methylation cycle disruption correlates to several health problems such as cardiovascular diseases and mental health disorders as well as fertility issues and cancer development. The methylation process depends on folate which generates active methylfolate (5-methyl THF) that helps transform dangerous homocysteine into methionine. The methionine produced by these pathways transforms into SAM-e (S-adenosyl-methionine) which supplies essential methyl groups needed for methylation processes. The AHCY gene produces the SAHH enzyme which transforms S-adenosylhomocysteine into adenosine and homocysteine to maintain the methylation cycle. The scientific evidence about two rare AHCY gene variants rs41301825-T and rs13043752-A that potentially change enzyme structure and lower its activity is still insufficient. Scientists must conduct additional studies to determine how these genetic variants affect methylation and health outcomes. Research has shown that the rs13043752 variant correlates with venous thrombosis regardless of homocysteine levels which demonstrates the intricate nature of genetic factors affecting health results. While individuals with uncommon AHCY mutations can display significant SAHH deficiency this report excludes those mutations and does not diagnose any health conditions. Scientific research provides minimal evidence to support the current genetic model of AHCY which requires further investigation to establish genetic predispositions conclusively. Precision Health & Wellness tests from PlexusDx offer insights into genetic makeup that reveal potential impacts on health for those interested in genetics-health connections. Begin your tailored genetic exploration today by visiting PlexusDx.com as well as checking Amazon and Walmart. The AHCY gene serves as a critical element in methylation processes and homocysteine metabolism which provides insight into the complex biological systems that maintain human health. Understanding our genetic blueprint reveals essential information about our bodies which helps us make better health-related choices. Discover personalized genetic testing through PlexusDx and take the first step toward achieving enhanced health and wellness.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.